A novel ASXL1–OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies
Daichi Inoue(Tokyo University of Science), Toshio Kitamura(National Agriculture and Food Research Organization), Takeshi Fujino(Memorial Sloan Kettering Cancer Center), Sayuri Horikawa(The University of Tokyo), Mingjiang Xu(The University of Texas at San Antonio Health Science Center), Reina Nagase(The University of Tokyo), Hiroko Kozuka‐Hata(Systems Biology Institute), Paul Sheridan(The University of Tokyo), Akihiko Yokoyama(Chiba Cancer Center), Zaomin Li(University of Miami), Hirotaka Matsui(Hiroshima University), Akinori Kanai(Frontier Medical College), Rui Yamaguchi, Masaaki Oyama(The University of Tokyo), Susumu Goyama(The University of Tokyo), Satoru Miyano(Cardiovascular Institute Hospital), Seiya Imoto(Tokyo Medical University), Feng‐Chun Yang(The University of Texas at San Antonio Health Science Center), Yaozhong Zhang(The University of Tokyo), Kimihito C. Kawabata(The University of Tokyo), Makoto Saika(The University of Tokyo), Toshiya Inaba(Hiroshima University)
Cited by 74
Related Papers
Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders
|Science|2021|434
Identification and Characterization of a Constitutively Active STAT5 Mutant That Promotes Cell Proliferation
|Molecular and Cellular Biology|1998|413
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation
|Blood|2017|352
The SOCS Box of SOCS-1 Accelerates Ubiquitin-dependent Proteolysis of TEL-JAK2
|Journal of Biological Chemistry|2001|306